Literature DB >> 36097117

A comprehensive review on methotrexate containing nanoparticles; an appropriate tool for cancer treatment.

Hanifeh Shariatifar1, Fateme Ranjbarian2, Fahimeh Hajiahmadi3, Alireza Farasat4.   

Abstract

For more than seven decades, methotrexate has been used all over the world for treatment of different diseases such as: cancer, autoimmune diseases, and rheumatoid arthritis. Several studies have addressed its formula, efficacy, and delivery methods in recent years. These studies have been focused on the effectiveness of different nanoparticles on drug delivery, delivery of the drug to the target cells, and attenuation of harm to the host cell. Whereas, the main usages of methotrexate are in cancer treatment field, this review provided a brief perspective into using different nanoparticles and their role in the treatment of different cancers.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cancer; Methotrexate (MTX); Nanoparticles

Year:  2022        PMID: 36097117     DOI: 10.1007/s11033-022-07782-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  53 in total

Review 1.  A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis.

Authors:  Samira Sadat Abolmaali; Ali Mohammad Tamaddon; Rassoul Dinarvand
Journal:  Cancer Chemother Pharmacol       Date:  2013-01-06       Impact factor: 3.333

Review 2.  The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?

Authors:  Linda E Kelemen
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

3.  Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.

Authors:  Mara Ferreira; Luíse L Chaves; Sofia A Costa Lima; Salette Reis
Journal:  Int J Pharm       Date:  2015-07-10       Impact factor: 5.875

4.  A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.

Authors:  H K Choi; J D Seeger; K M Kuntz
Journal:  Arthritis Rheum       Date:  2000-10

Review 5.  Methotrexate: a detailed review on drug delivery and clinical aspects.

Authors:  Zulfequar Ahamad Khan; Rahul Tripathi; Brahmeshwar Mishra
Journal:  Expert Opin Drug Deliv       Date:  2012-02       Impact factor: 6.648

6.  Pharmacokinetics of oral methotrexate in children.

Authors:  F M Balis; J L Savitch; W A Bleyer
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

7.  Methotrexate therapy in rheumatoid arthritis: 15 years experience.

Authors:  R T Hoffmeister
Journal:  Am J Med       Date:  1983-12-30       Impact factor: 4.965

8.  Analogues of methotrexate and aminopterin with gamma-methylene and gamma-cyano substitution of the glutamate side chain: synthesis and in vitro biological activity.

Authors:  A Rosowsky; H Bader; J H Freisheim
Journal:  J Med Chem       Date:  1991-01       Impact factor: 7.446

9.  Cancer chemotherapy: targeting folic acid synthesis.

Authors:  Nicole Hagner; Markus Joerger
Journal:  Cancer Manag Res       Date:  2010-11-19       Impact factor: 3.989

10.  Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment.

Authors:  Dan Xu; Shu-Ting Lu; Yu-Shuang Li; Aju Baidya; Hao Mei; Yong He; Bo Wu
Journal:  Drug Des Devel Ther       Date:  2018-10-05       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.